论著

NLRP3基因变异致自身炎症性疾病6例患儿的早期诊断、治疗及随访研究

  • 黄诗喻 ,
  • 罗丽娟 ,
  • 王静 ,
  • 陈霞 ,
  • 曹清
展开
  • 上海交通大学医学院附属上海儿童医学中心感染科(上海 200127)

收稿日期: 2024-01-10

  网络出版日期: 2024-07-08

Early diagnosis, treatment and follow-up of 6 children with autoinflammatory diseases caused by NLRP3 gene variation

  • Shiyu HUANG ,
  • Lijuan LUO ,
  • Jing WANG ,
  • Xia CHEN ,
  • Qing CAO
Expand
  • Department of Infectious Disease, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China

Received date: 2024-01-10

  Online published: 2024-07-08

摘要

目的 分析NLRP3基因变异致自身炎症性疾病患儿的临床特点,为此类患儿的诊治提供依据。方法 选取2017年2月至2023年3月确诊的NLRP3基因变异致自身炎症性疾病患儿作为研究对象进行回顾性分析。结果 共6例患儿纳入,其中男性3例,女性3例。所有患儿均在婴幼儿期发病,5例反复发热。6例皮疹,确诊前误诊为荨麻疹或过敏性皮炎;1例因关节肿痛曾误诊为幼年特发性关节炎;4例行腰穿检查误诊为化脓性脑膜炎;2例有听力受损;1例全身多器官受累明显。6例在发病期间均观察到白细胞增多,5例检测到C反应蛋白升高,4例血沉增高,4例血清淀粉样蛋白A(SAA)增高,5例贫血,4例白细胞介素6(IL-6)升高,2例白细胞介素1β(IL-1β)升高。4例患儿应用卡那单抗治疗,频率为每8周注射1次,最长随访3年,目前一般情况良好。结论 NLRP3基因变异致自身炎症性疾病临床表现不典型,早期诊断以及早期应用IL-1β拮抗剂如卡那单抗治疗有良好的效果,可显著改善临床症状。

本文引用格式

黄诗喻 , 罗丽娟 , 王静 , 陈霞 , 曹清 . NLRP3基因变异致自身炎症性疾病6例患儿的早期诊断、治疗及随访研究[J]. 临床儿科杂志, 2024 , 42(7) : 643 -647 . DOI: 10.12372/jcp.2024.24e0039

Abstract

Objective To analyze the clinical features of children with autoinflammatory disease caused by NLRP3 gene variation, and to provide basis for diagnosis and treatment of such children. Methods A retrospective study was conducted on 6 patients diagnosed with autoinflammatory disease caused by NLRP3 gene variation from February 2017 to March 2023. Results A total of 6 children (3 boys and 3 girls) were included. All of the patients developed symptoms in early childhood, with recurrent fever in 5 cases and rash in 6 cases. Before diagnosis, the patients were misdiagnosed as urticaria or atopic dermatitis. One case was misdiagnosed as juvenile idiopathic arthritis due to joint swelling and pain. Four patients were misdiagnosed as suppurative meningitis by lumbar puncture examination and 2 had hearing impairment. One case had obvious multi-organ involvement. Leukocytosis was observed in all 6 cases. C-reactive protein was increased in 5 cases, erythrocyte sedimentation rate was increased in 4 cases, serum amyloid A (SAA) was increased in 4 cases, interleukin-6 (IL-6) was increased in 4 cases, and interleukin-1β (IL-1β) was increased in 2 cases. Five patients had anemia. Four patients were treated with canakinumab by injection every 8 weeks. The patients were followed up for up to 3 years and were generally in good condition. Conclusions NLRP3 gene variations can lead to atypical clinical manifestations of autoinflammatory diseases. Prompt diagnosis and early treatment with IL-1β antagonists like canakinumab supplementation have shown good efficacy in significantly improving clinical symptoms.

参考文献

[1] Broderick L. Hereditary autoinflammatory disorders: recognition and treatment[J]. Immunol Allergy Clin North Am, 2019, 39(1): 13-29.
[2] Krainer J, Siebenhandl S, Weinh?usel A. Systemic autoinflammatory diseases[J]. J Autoimmun, 2020, 109: 102421.
[3] Aksentijevich I, Putnam CD, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model[J]. Arthritis Rheum, 2007, 56(4): 1273-1285.
[4] Malcova H, Strizova Z, Milota T, et al. IL-1 Inhibitors in the treatment of monogenic periodic fever syndromes: from the past to the future perspectives[J]. Front Immunol, 2021, 11: 619257.
[5] Welzel T, Kuemmerle-Deschner JB. Diagnosis and management of the cryopyrin-associated periodic syndromes (CAPS): what do we know today?[J]. J Clin Med, 2021, 10(1): 128.
[6] Kapur S, Bonk ME. Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes[J]. P T, 2009, 34(3): 138-141.
[7] Feldmann J, Prieur AM, Quartier P, et al. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes[J]. Am J Hum Genet, 2002, 71(1): 198-203.
[8] Aksentijevich I, Nowak M, Mallah M, et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases[J]. Arthritis Rheum, 2002, 46(12): 3340-3348.
[9] 张俊梅, 李彩凤, 檀晓华, 等. 慢性婴儿神经皮肤关节综合征十例基因变异临床表型及治疗随访分析[J]. 中华风湿病学杂志, 2019, 23(8): 536-539.
[10] Shen M, Qing Y, Shi X, et al. Recommendations of diagnosis of autoinflammatory diseases in China[J]. Zhonghua Nei Ke Za Zhi, 2021, 60(12): 1129-1138.
[11] 中华医学会儿科学分会风湿病学组, 中国医师协会风湿免疫科医师分会儿科学组, 海峡两岸医药卫生交流协会风湿免疫病学专业委员会儿童学组, 等. 儿童自身炎症性疾病诊断与治疗专家共识[J]. 中华实用儿科临床杂志, 2022, 37(3): 161-172.
[12] Turunen JA, Wedenoja J, Repo P, et al. Keratoendotheliitis fugax hereditaria: a novel cryopyrin-associated periodic syndrome caused by a mutation in the nucleotide-binding domain, leucine-rich repeat family, pyrin domain-containing 3 (NLRP3) gene[J]. Am J Ophthalmol, 2018, 188: 41-50.
[13] Ducharme-BéNard S, Roberge G, Chapdelaine H. A unique presentation of NLRP3-associated autoinflammatory disease: case report[J]. BMC Rheumatology, 2022, 6(1): 91.
[14] Papa R, Doglio M, Lachmann HJ, et al. A web-based collection of genotype-phenotype associations in hereditary recurrent fevers from the Eurofever registry[J]. Orphanet J Rare Dis, 2017, 12(1): 167.
[15] Dalgic B, Egritas O, Sari S, et al. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra[J]. Pediatr Nephrol, 2007, 22(9):1391-1394.
[16] Samson JM, Ravindran Menon D, Vaddi PK, et al. Computational modeling of NLRP3 identifies enhanced ATP binding and multimerization in cryopyrin-associated periodic syndromes[J]. Front Immunol, 2020, 11: 584364.
[17] 马明圣, 王薇, 周煜, 等. 炎症小体病35例临床特征分析[J]. 中华儿科杂志, 2022, 60(2): 114-118.
[18] Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases[J]. Blood, 2011, 117(14): 3720-3732.
[19] Kuemmerle-Deschner JB. CAPS — pathogenesis, presentation and treatment of an autoinflammatory disease[J]. Semin Immunopathol, 2015, 37(4): 377-385.
[20] Hashkes PJ, Lovell DJ. Recognition of infantile-onset multisystem inflammatory disease as a unique entity[J]. J Pediatr, 1997, 130(4): 513-515.
[21] Li C, Tan X, Zhang J, et al. Gene mutations and clinical phenotypes in 15 Chinese children with cryopyrin-associated periodic syndrome (CAPS)[J]. Sci China Life Sci, 2017, 60(12): 1436-1444.
[22] Zhou Y, Wang W, Zhong L, et al. Clinical and genetic spectrum of 14 cases of NLRP3-associated autoinflammatory disease (NLRP3-AID) in China and a review of the literature[J]. Orphanet J Rare Dis, 2022, 17(1): 214.
文章导航

/